SARS-Cov-2 Vaccine and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 SARS-Cov-2 Vaccine (Vero Cell) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global SARS-Cov-2 Vaccine (Vero Cell) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global SARS-Cov-2 Vaccine (Vero Cell) Overall Market Size
2.1 Global SARS-Cov-2 Vaccine (Vero Cell) Market Size: 2021 VS 2028
2.2 Global SARS-Cov-2 Vaccine (Vero Cell) Revenue, Prospects & Forecasts: 2017-2028
2.3 Global SARS-Cov-2 Vaccine (Vero Cell) Sales: 2017-2028
3 Company Landscape
3.1 Top SARS-Cov-2 Vaccine (Vero Cell) Players in Global Market
3.2 Top Global SARS-Cov-2 Vaccine (Vero Cell) Companies Ranked by Revenue
3.3 Global SARS-Cov-2 Vaccine (Vero Cell) Revenue by Companies
3.4 Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Companies
3.5 Global SARS-Cov-2 Vaccine (Vero Cell) Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 SARS-Cov-2 Vaccine (Vero Cell) Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers SARS-Cov-2 Vaccine (Vero Cell) Product Type
3.8 Tier 1, Tier 2 and Tier 3 SARS-Cov-2 Vaccine (Vero Cell) Players in Global Market
3.8.1 List of Global Tier 1 SARS-Cov-2 Vaccine (Vero Cell) Companies
3.8.2 List of Global Tier 2 and Tier 3 SARS-Cov-2 Vaccine (Vero Cell) Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global SARS-Cov-2 Vaccine (Vero Cell) Market Size Markets, 2021 & 2028
4.1.2 Whole Virus Inactivated Vaccine
4.1.3 Split Vaccine
4.1.4 Subunit Vaccine
4.1.5 Others
4.2 By Type - Global SARS-Cov-2 Vaccine (Vero Cell) Revenue & Forecasts
4.2.1 By Type - Global SARS-Cov-2 Vaccine (Vero Cell) Revenue, 2017-2022
4.2.2 By Type - Global SARS-Cov-2 Vaccine (Vero Cell) Revenue, 2023-2028
4.2.3 By Type - Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share, 2017-2028
4.3 By Type - Global SARS-Cov-2 Vaccine (Vero Cell) Sales & Forecasts
4.3.1 By Type - Global SARS-Cov-2 Vaccine (Vero Cell) Sales, 2017-2022
4.3.2 By Type - Global SARS-Cov-2 Vaccine (Vero Cell) Sales, 2023-2028
4.3.3 By Type - Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share, 2017-2028
4.4 By Type - Global SARS-Cov-2 Vaccine (Vero Cell) Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global SARS-Cov-2 Vaccine (Vero Cell) Market Size, 2021 & 2028
5.1.2 Special Population
5.1.3 General Population
5.2 By Application - Global SARS-Cov-2 Vaccine (Vero Cell) Revenue & Forecasts
5.2.1 By Application - Global SARS-Cov-2 Vaccine (Vero Cell) Revenue, 2017-2022
5.2.2 By Application - Global SARS-Cov-2 Vaccine (Vero Cell) Revenue, 2023-2028
5.2.3 By Application - Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share, 2017-2028
5.3 By Application - Global SARS-Cov-2 Vaccine (Vero Cell) Sales & Forecasts
5.3.1 By Application - Global SARS-Cov-2 Vaccine (Vero Cell) Sales, 2017-2022
5.3.2 By Application - Global SARS-Cov-2 Vaccine (Vero Cell) Sales, 2023-2028
5.3.3 By Application - Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share, 2017-2028
5.4 By Application - Global SARS-Cov-2 Vaccine (Vero Cell) Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global SARS-Cov-2 Vaccine (Vero Cell) Market Size, 2021 & 2028
6.2 By Region - Global SARS-Cov-2 Vaccine (Vero Cell) Revenue & Forecasts
6.2.1 By Region - Global SARS-Cov-2 Vaccine (Vero Cell) Revenue, 2017-2022
6.2.2 By Region - Global SARS-Cov-2 Vaccine (Vero Cell) Revenue, 2023-2028
6.2.3 By Region - Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share, 2017-2028
6.3 By Region - Global SARS-Cov-2 Vaccine (Vero Cell) Sales & Forecasts
6.3.1 By Region - Global SARS-Cov-2 Vaccine (Vero Cell) Sales, 2017-2022
6.3.2 By Region - Global SARS-Cov-2 Vaccine (Vero Cell) Sales, 2023-2028
6.3.3 By Region - Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America SARS-Cov-2 Vaccine (Vero Cell) Revenue, 2017-2028
6.4.2 By Country - North America SARS-Cov-2 Vaccine (Vero Cell) Sales, 2017-2028
6.4.3 US SARS-Cov-2 Vaccine (Vero Cell) Market Size, 2017-2028
6.4.4 Canada SARS-Cov-2 Vaccine (Vero Cell) Market Size, 2017-2028
6.4.5 Mexico SARS-Cov-2 Vaccine (Vero Cell) Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe SARS-Cov-2 Vaccine (Vero Cell) Revenue, 2017-2028
6.5.2 By Country - Europe SARS-Cov-2 Vaccine (Vero Cell) Sales, 2017-2028
6.5.3 Germany SARS-Cov-2 Vaccine (Vero Cell) Market Size, 2017-2028
6.5.4 France SARS-Cov-2 Vaccine (Vero Cell) Market Size, 2017-2028
6.5.5 U.K. SARS-Cov-2 Vaccine (Vero Cell) Market Size, 2017-2028
6.5.6 Italy SARS-Cov-2 Vaccine (Vero Cell) Market Size, 2017-2028
6.5.7 Russia SARS-Cov-2 Vaccine (Vero Cell) Market Size, 2017-2028
6.5.8 Nordic Countries SARS-Cov-2 Vaccine (Vero Cell) Market Size, 2017-2028
6.5.9 Benelux SARS-Cov-2 Vaccine (Vero Cell) Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia SARS-Cov-2 Vaccine (Vero Cell) Revenue, 2017-2028
6.6.2 By Region - Asia SARS-Cov-2 Vaccine (Vero Cell) Sales, 2017-2028
6.6.3 China SARS-Cov-2 Vaccine (Vero Cell) Market Size, 2017-2028
6.6.4 Japan SARS-Cov-2 Vaccine (Vero Cell) Market Size, 2017-2028
6.6.5 South Korea SARS-Cov-2 Vaccine (Vero Cell) Market Size, 2017-2028
6.6.6 Southeast Asia SARS-Cov-2 Vaccine (Vero Cell) Market Size, 2017-2028
6.6.7 India SARS-Cov-2 Vaccine (Vero Cell) Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America SARS-Cov-2 Vaccine (Vero Cell) Revenue, 2017-2028
6.7.2 By Country - South America SARS-Cov-2 Vaccine (Vero Cell) Sales, 2017-2028
6.7.3 Brazil SARS-Cov-2 Vaccine (Vero Cell) Market Size, 2017-2028
6.7.4 Argentina SARS-Cov-2 Vaccine (Vero Cell) Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Sales, 2017-2028
6.8.3 Turkey SARS-Cov-2 Vaccine (Vero Cell) Market Size, 2017-2028
6.8.4 Israel SARS-Cov-2 Vaccine (Vero Cell) Market Size, 2017-2028
6.8.5 Saudi Arabia SARS-Cov-2 Vaccine (Vero Cell) Market Size, 2017-2028
6.8.6 UAE SARS-Cov-2 Vaccine (Vero Cell) Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Sinopharm
7.1.1 Sinopharm Corporate Summary
7.1.2 Sinopharm Business Overview
7.1.3 Sinopharm SARS-Cov-2 Vaccine (Vero Cell) Major Product Offerings
7.1.4 Sinopharm SARS-Cov-2 Vaccine (Vero Cell) Sales and Revenue in Global (2017-2022)
7.1.5 Sinopharm Key News
7.2 Sinovac Biotech
7.2.1 Sinovac Biotech Corporate Summary
7.2.2 Sinovac Biotech Business Overview
7.2.3 Sinovac Biotech SARS-Cov-2 Vaccine (Vero Cell) Major Product Offerings
7.2.4 Sinovac Biotech SARS-Cov-2 Vaccine (Vero Cell) Sales and Revenue in Global (2017-2022)
7.2.5 Sinovac Biotech Key News
7.3 BIBP
7.3.1 BIBP Corporate Summary
7.3.2 BIBP Business Overview
7.3.3 BIBP SARS-Cov-2 Vaccine (Vero Cell) Major Product Offerings
7.3.4 BIBP SARS-Cov-2 Vaccine (Vero Cell) Sales and Revenue in Global (2017-2022)
7.3.5 BIBP Key News
7.4 IMBCAMS,China
7.4.1 IMBCAMS,China Corporate Summary
7.4.2 IMBCAMS,China Business Overview
7.4.3 IMBCAMS,China SARS-Cov-2 Vaccine (Vero Cell) Major Product Offerings
7.4.4 IMBCAMS,China SARS-Cov-2 Vaccine (Vero Cell) Sales and Revenue in Global (2017-2022)
7.4.5 IMBCAMS,China Key News
7.5 WIBP
7.5.1 WIBP Corporate Summary
7.5.2 WIBP Business Overview
7.5.3 WIBP SARS-Cov-2 Vaccine (Vero Cell) Major Product Offerings
7.5.4 WIBP SARS-Cov-2 Vaccine (Vero Cell) Sales and Revenue in Global (2017-2022)
7.5.5 WIBP Key News
8 Global SARS-Cov-2 Vaccine (Vero Cell) Production Capacity, Analysis
8.1 Global SARS-Cov-2 Vaccine (Vero Cell) Production Capacity, 2017-2028
8.2 SARS-Cov-2 Vaccine (Vero Cell) Production Capacity of Key Manufacturers in Global Market
8.3 Global SARS-Cov-2 Vaccine (Vero Cell) Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 SARS-Cov-2 Vaccine (Vero Cell) Supply Chain Analysis
10.1 SARS-Cov-2 Vaccine (Vero Cell) Industry Value Chain
10.2 SARS-Cov-2 Vaccine (Vero Cell) Upstream Market
10.3 SARS-Cov-2 Vaccine (Vero Cell) Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 SARS-Cov-2 Vaccine (Vero Cell) Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of SARS-Cov-2 Vaccine (Vero Cell) in Global Market
Table 2. Top SARS-Cov-2 Vaccine (Vero Cell) Players in Global Market, Ranking by Revenue (2021)
Table 3. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Share by Companies, 2017-2022
Table 5. Global SARS-Cov-2 Vaccine (Vero Cell) Sales by Companies, (K Units), 2017-2022
Table 6. Global SARS-Cov-2 Vaccine (Vero Cell) Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers SARS-Cov-2 Vaccine (Vero Cell) Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers SARS-Cov-2 Vaccine (Vero Cell) Product Type
Table 9. List of Global Tier 1 SARS-Cov-2 Vaccine (Vero Cell) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 SARS-Cov-2 Vaccine (Vero Cell) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global SARS-Cov-2 Vaccine (Vero Cell) Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global SARS-Cov-2 Vaccine (Vero Cell) Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global SARS-Cov-2 Vaccine (Vero Cell) Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units), 2017-2022
Table 15. By Type - Global SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units), 2023-2028
Table 16. By Application ? Global SARS-Cov-2 Vaccine (Vero Cell) Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global SARS-Cov-2 Vaccine (Vero Cell) Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global SARS-Cov-2 Vaccine (Vero Cell) Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units), 2017-2022
Table 20. By Application - Global SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units), 2023-2028
Table 21. By Region ? Global SARS-Cov-2 Vaccine (Vero Cell) Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global SARS-Cov-2 Vaccine (Vero Cell) Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global SARS-Cov-2 Vaccine (Vero Cell) Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units), 2017-2022
Table 25. By Region - Global SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units), 2023-2028
Table 26. By Country - North America SARS-Cov-2 Vaccine (Vero Cell) Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America SARS-Cov-2 Vaccine (Vero Cell) Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America SARS-Cov-2 Vaccine (Vero Cell) Sales, (K Units), 2017-2022
Table 29. By Country - North America SARS-Cov-2 Vaccine (Vero Cell) Sales, (K Units), 2023-2028
Table 30. By Country - Europe SARS-Cov-2 Vaccine (Vero Cell) Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe SARS-Cov-2 Vaccine (Vero Cell) Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe SARS-Cov-2 Vaccine (Vero Cell) Sales, (K Units), 2017-2022
Table 33. By Country - Europe SARS-Cov-2 Vaccine (Vero Cell) Sales, (K Units), 2023-2028
Table 34. By Region - Asia SARS-Cov-2 Vaccine (Vero Cell) Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia SARS-Cov-2 Vaccine (Vero Cell) Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia SARS-Cov-2 Vaccine (Vero Cell) Sales, (K Units), 2017-2022
Table 37. By Region - Asia SARS-Cov-2 Vaccine (Vero Cell) Sales, (K Units), 2023-2028
Table 38. By Country - South America SARS-Cov-2 Vaccine (Vero Cell) Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America SARS-Cov-2 Vaccine (Vero Cell) Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America SARS-Cov-2 Vaccine (Vero Cell) Sales, (K Units), 2017-2022
Table 41. By Country - South America SARS-Cov-2 Vaccine (Vero Cell) Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Sales, (K Units), 2023-2028
Table 46. Sinopharm Corporate Summary
Table 47. Sinopharm SARS-Cov-2 Vaccine (Vero Cell) Product Offerings
Table 48. Sinopharm SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Sinovac Biotech Corporate Summary
Table 50. Sinovac Biotech SARS-Cov-2 Vaccine (Vero Cell) Product Offerings
Table 51. Sinovac Biotech SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. BIBP Corporate Summary
Table 53. BIBP SARS-Cov-2 Vaccine (Vero Cell) Product Offerings
Table 54. BIBP SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. IMBCAMS,China Corporate Summary
Table 56. IMBCAMS,China SARS-Cov-2 Vaccine (Vero Cell) Product Offerings
Table 57. IMBCAMS,China SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. WIBP Corporate Summary
Table 59. WIBP SARS-Cov-2 Vaccine (Vero Cell) Product Offerings
Table 60. WIBP SARS-Cov-2 Vaccine (Vero Cell) Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. SARS-Cov-2 Vaccine (Vero Cell) Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 62. Global SARS-Cov-2 Vaccine (Vero Cell) Capacity Market Share of Key Manufacturers, 2020-2022
Table 63. Global SARS-Cov-2 Vaccine (Vero Cell) Production by Region, 2017-2022 (K Units)
Table 64. Global SARS-Cov-2 Vaccine (Vero Cell) Production by Region, 2023-2028 (K Units)
Table 65. SARS-Cov-2 Vaccine (Vero Cell) Market Opportunities & Trends in Global Market
Table 66. SARS-Cov-2 Vaccine (Vero Cell) Market Drivers in Global Market
Table 67. SARS-Cov-2 Vaccine (Vero Cell) Market Restraints in Global Market
Table 68. SARS-Cov-2 Vaccine (Vero Cell) Raw Materials
Table 69. SARS-Cov-2 Vaccine (Vero Cell) Raw Materials Suppliers in Global Market
Table 70. Typical SARS-Cov-2 Vaccine (Vero Cell) Downstream
Table 71. SARS-Cov-2 Vaccine (Vero Cell) Downstream Clients in Global Market
Table 72. SARS-Cov-2 Vaccine (Vero Cell) Distributors and Sales Agents in Global Market
List of Figures
Figure 1. SARS-Cov-2 Vaccine (Vero Cell) Segment by Type
Figure 2. SARS-Cov-2 Vaccine (Vero Cell) Segment by Application
Figure 3. Global SARS-Cov-2 Vaccine (Vero Cell) Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global SARS-Cov-2 Vaccine (Vero Cell) Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global SARS-Cov-2 Vaccine (Vero Cell) Revenue, 2017-2028 (US$, Mn)
Figure 7. SARS-Cov-2 Vaccine (Vero Cell) Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by SARS-Cov-2 Vaccine (Vero Cell) Revenue in 2021
Figure 9. By Type - Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share, 2017-2028
Figure 10. By Type - Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share, 2017-2028
Figure 11. By Type - Global SARS-Cov-2 Vaccine (Vero Cell) Price (US$/Unit), 2017-2028
Figure 12. By Application - Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share, 2017-2028
Figure 13. By Application - Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share, 2017-2028
Figure 14. By Application - Global SARS-Cov-2 Vaccine (Vero Cell) Price (US$/Unit), 2017-2028
Figure 15. By Region - Global SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share, 2017-2028
Figure 16. By Region - Global SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share, 2017-2028
Figure 17. By Country - North America SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share, 2017-2028
Figure 18. By Country - North America SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share, 2017-2028
Figure 19. US SARS-Cov-2 Vaccine (Vero Cell) Revenue, (US$, Mn), 2017-2028
Figure 20. Canada SARS-Cov-2 Vaccine (Vero Cell) Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico SARS-Cov-2 Vaccine (Vero Cell) Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share, 2017-2028
Figure 23. By Country - Europe SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share, 2017-2028
Figure 24. Germany SARS-Cov-2 Vaccine (Vero Cell) Revenue, (US$, Mn), 2017-2028
Figure 25. France SARS-Cov-2 Vaccine (Vero Cell) Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. SARS-Cov-2 Vaccine (Vero Cell) Revenue, (US$, Mn), 2017-2028
Figure 27. Italy SARS-Cov-2 Vaccine (Vero Cell) Revenue, (US$, Mn), 2017-2028
Figure 28. Russia SARS-Cov-2 Vaccine (Vero Cell) Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries SARS-Cov-2 Vaccine (Vero Cell) Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux SARS-Cov-2 Vaccine (Vero Cell) Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share, 2017-2028
Figure 32. By Region - Asia SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share, 2017-2028
Figure 33. China SARS-Cov-2 Vaccine (Vero Cell) Revenue, (US$, Mn), 2017-2028
Figure 34. Japan SARS-Cov-2 Vaccine (Vero Cell) Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea SARS-Cov-2 Vaccine (Vero Cell) Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia SARS-Cov-2 Vaccine (Vero Cell) Revenue, (US$, Mn), 2017-2028
Figure 37. India SARS-Cov-2 Vaccine (Vero Cell) Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share, 2017-2028
Figure 39. By Country - South America SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share, 2017-2028
Figure 40. Brazil SARS-Cov-2 Vaccine (Vero Cell) Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina SARS-Cov-2 Vaccine (Vero Cell) Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa SARS-Cov-2 Vaccine (Vero Cell) Sales Market Share, 2017-2028
Figure 44. Turkey SARS-Cov-2 Vaccine (Vero Cell) Revenue, (US$, Mn), 2017-2028
Figure 45. Israel SARS-Cov-2 Vaccine (Vero Cell) Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia SARS-Cov-2 Vaccine (Vero Cell) Revenue, (US$, Mn), 2017-2028
Figure 47. UAE SARS-Cov-2 Vaccine (Vero Cell) Revenue, (US$, Mn), 2017-2028
Figure 48. Global SARS-Cov-2 Vaccine (Vero Cell) Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production SARS-Cov-2 Vaccine (Vero Cell) by Region, 2021 VS 2028
Figure 50. SARS-Cov-2 Vaccine (Vero Cell) Industry Value Chain
Figure 51. Marketing Channels
Industry Market Size
